MSD - Latest News [Page 1]

KEYTRUDA® registered for treatment of lung cancer

Friday, 21 April 2017, 12:43 pm | MSD

April 20, 2017, Merck Sharp & Dohme Limited (MSD) today announced KEYTRUDA® (pembrolizumab) has now received its second Medsafe registration for lung cancer. More >>

KEYTRUDA funded for melanoma, new indications in process

Tuesday, 2 August 2016, 2:31 pm | MSD

MSD is pleased that PHARMAC has announced it will fund anti-PD1 immunotherapy medicine KEYTRUDA® (pembrolizumab) for the treatment of advanced melanoma that has spread through the body – effective from September 1. Mr Paul Smith, MSD New Zealand Director, ... More >>

MSD signs KEYTRUDA agreement and offers bridging programme

Tuesday, 28 June 2016, 3:51 pm | MSD

MSD has signed a provisional agreement with PHARMAC (subject to stakeholder consultation and PHARMAC board approval) to fund MSD’s anti-PD1 immunotherapy KEYTRUDA® (pembrolizumab) for the treatment of advanced melanoma that has spread. Mr Paul Smith, MSD New Zealand ... More >>

Covering risk from abortion losses

Tuesday, 2 February 2016, 1:24 pm | MSD

Losing healthy sets of twins through abortion when you’ve worked so hard to get them safely to this point is “heart-breaking”, says Southland farmer Shane Roy. More >>

New Zealand Doctors Can Now Access Univadis®

Monday, 3 August 2015, 11:41 am | MSD

New Zealand doctors now have access to Univadis, a free medical education and unbiased health information website for healthcare professionals. More >>

Funded Gastroenteritis Vaccine for Babies Nearly Here!

Tuesday, 24 June 2014, 12:18 pm | MSD

Soon babies born in New Zealand will be eligible for funded vaccination against rotavirus gastroenteritis caused by rotavirus infection. PHARMAC has funded ROTATEQ® (rotavirus vaccine, live, oral, pentavalent) and added it to the Immunisation Schedule from ... More >>

New Zealanders flock to get shingles vaccine

Monday, 9 June 2014, 1:00 pm | MSD

New Zealanders have flocked to surgeries in recent months to get the world’s first and only vaccine, ZOSTAVAX™, that helps protect against the acute and chronic pain of shingles. Shingles affects up to 1 in 3 people, who have had chickenpox, during ... More >>

NZ Women Now Have Access to New Once Monthly Vaginal Ring

Tuesday, 3 December 2013, 2:27 pm | MSD

For women who don’t want the hassle of a daily contraceptive, there is now a new once monthly contraception option - NuvaRing® (120mcg etonogestrel / 15mcg ethinyl estradiol per day). More >>

 

InfoPages Links

 
 
 

LATEST HEADLINES

 
 
 
InfoPages
Search Scoop  
 
 
Powered by Vodafone
NZ independent news